{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:52:25Z","timestamp":1788522745527,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770876"],"award-info":[{"award-number":["81770876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20191141"],"award-info":[{"award-number":["BK20191141"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ebiom.2020.102715","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T19:55:47Z","timestamp":1585943747000},"page":"102715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation"],"prefix":"10.1016","volume":"54","author":[{"given":"Yi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Li","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Dong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Zhong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Lai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2020.102715_bib0001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1468-3083.2011.04200.x","article-title":"Extracellular matrix molecules implicated in hypertrophic and keloid scarring","volume":"26","author":"Sidgwick","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ebiom.2020.102715_bib0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biopha.2016.09.010","article-title":"Growth factor pathways in hypertrophic scars: molecular pathogenesis and therapeutic implications","volume":"84","author":"Lian","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2020.102715_bib0003","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.ebiom.2020.102715_bib0004","article-title":"Comparative efficacy and safety of common therapies in keloids and hypertrophic scars: a systematic review and meta-analysis","author":"Bao","year":"2019","journal-title":"Aesthetic Plast Surg"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2020.102715_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","volume":"43","author":"Berman","year":"2017","journal-title":"Dermatol Surg"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102715_bib0006","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","article-title":"The hidden cost of skin scars: quality of life after skin scarring","volume":"61","author":"Brown","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102715_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MOO.0000000000000268","article-title":"Advances in scar management: prevention and management of hypertrophic scars and keloids","volume":"24","author":"Del Toro","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ebiom.2020.102715_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13126","article-title":"Combined treatment of hypertrophic and keloid scars with intra-lesional injection of corticosteroids and laser-assisted corticosteroid delivery","author":"Benzaquen","year":"2019","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102715_bib0009","first-page":"171","article-title":"The role of myofibroblasts in wound healing","volume":"64","author":"Hinz","year":"2016","journal-title":"Curr Res Transl Med"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102715_bib0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cbin.10265","article-title":"Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin alpha","volume":"38","author":"Chen","year":"2014","journal-title":"TGF-beta and alpha-SMA. Cell Biol Int"},{"key":"10.1016\/j.ebiom.2020.102715_bib0011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2119\/molmed.2014.00172","article-title":"miR-145 contributes to hypertrophic scarring of the skin by inducing myofibroblast activity","volume":"21","author":"Gras","year":"2015","journal-title":"Mol Med"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102715_bib0012","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00018-015-2110-0","article-title":"The myofibroblast, a key cell in normal and pathological tissue repair","volume":"73","author":"Darby","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ebiom.2020.102715_bib0013","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-981-13-8871-2_12","article-title":"Myofibroblast in kidney fibrosis: origin, activation, and regulation","volume":"1165","author":"Yuan","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102715_bib0014","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1590\/abd1806-4841.20176656","article-title":"Wound natural healing in treatment of tumor-like hypertrophic scar","volume":"92","author":"Han","year":"2017","journal-title":"An Bras Dermatol"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102715_bib0015","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.bmcl.2013.07.032","article-title":"Syntheses and antitumor activities of N'1,N'3-dialkyl-N'1,N'3-di-(alkylcarbonothioyl) malonohydrazide: the discovery of elesclomol","volume":"23","author":"Chen","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102715_bib0016","doi-asserted-by":"crossref","first-page":"10564","DOI":"10.1002\/jcb.28342","article-title":"The outcomes of an impaired powerhouse in kras mutant lung adenocarcinoma cells by elesclomol","volume":"120","author":"Albayrak","year":"2019","journal-title":"J Cell Biochem"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102715_bib0017","doi-asserted-by":"crossref","first-page":"e40690","DOI":"10.1371\/journal.pone.0040690","article-title":"Mitochondrial respiration\u2013an important therapeutic target in melanoma","volume":"7","author":"Barbi de Moura","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102715_bib0018","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","article-title":"Final results of phase III symmetry study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma","volume":"31","author":"O'Day","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102715_bib0019","first-page":"574","article-title":"STA-4783\u2013enhancing taxane efficacy by induction of HSP70","volume":"7","author":"Gehrmann","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102715_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-009-0470-6","article-title":"Elesclomol, counteracted by AKT survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells","volume":"121","author":"Qu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ebiom.2020.102715_bib0021","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fphar.2017.00804","article-title":"Silencing of NAC1 expression induces cancer cells oxidative stress in hypoxia and potentiates the therapeutic activity of elesclomol","volume":"8","author":"Ren","year":"2017","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102715_bib0022","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","article-title":"Elesclomol induces cancer cell apoptosis through oxidative stress","volume":"7","author":"Kirshner","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102715_bib0023","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00006534-199709000-00021","article-title":"Acute and chronic animal models for excessive dermal scarring: quantitative studies","volume":"100","author":"Morris","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ebiom.2020.102715_bib0024","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-7113-8_19","article-title":"Type I collagen purification from rat tail tendons","volume":"1627","author":"Rittie","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102715_bib0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainresprot.2004.04.001","article-title":"Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined tunel and dapi staining","volume":"13","author":"Daniel","year":"2004","journal-title":"Brain Res Brain Res Protoc"},{"key":"10.1016\/j.ebiom.2020.102715_bib0026","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rvsc.2016.02.004","article-title":"Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: an immunohistochemical and prognostic study","volume":"105","author":"Dolka","year":"2016","journal-title":"Res Vet Sci"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102715_bib0027","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087312","article-title":"Detecting cleaved caspase-3 in apoptotic cells by flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102715_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00006534-200207000-00029","article-title":"Effect of mederma on hypertrophic scarring in the rabbit ear model","volume":"110","author":"Saulis","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102715_bib0029","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bjps.2008.03.022","article-title":"The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel","volume":"61","author":"Tandara","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ebiom.2020.102715_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s10735-019-09844-w","article-title":"Smad interacting protein 1 influences transforming growth factor-beta1\/Smad signaling in extracellular matrix protein production and hypertrophic scar formation","author":"Fang","year":"2019","journal-title":"J Mol Histol"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102715_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081256","article-title":"Systemic sclerosis serum steers the differentiation of adipose-derived stem cells toward profibrotic myofibroblasts: pathophysiologic implications","volume":"8","author":"Manetti","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ebiom.2020.102715_bib0032","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fbioe.2019.00196","article-title":"Investigating fibroblast-induced collagen gel contraction using a dynamic microscale platform","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"issue":"34","key":"10.1016\/j.ebiom.2020.102715_bib0033","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102715_bib0034","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.pharep.2016.04.010","article-title":"Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways","volume":"68","author":"Yang","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102715_bib0035","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2014.02.055","article-title":"The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C","volume":"157","author":"Yee","year":"2014","journal-title":"elegans. Cell"},{"key":"10.1016\/j.ebiom.2020.102715_bib0036","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-981-13-8367-0_5","article-title":"Crosstalk between oxidative stress and mitochondrial damage: focus on amyotrophic lateral sclerosis","volume":"1158","author":"Greco","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102715_bib0037","doi-asserted-by":"crossref","first-page":"e29798","DOI":"10.1371\/journal.pone.0029798","article-title":"Mitochondrial electron transport is the cellular target of the oncology drug elesclomol","volume":"7","author":"Blackman","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102715_bib0038","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102715_bib0039","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2174\/187152011796817691","article-title":"Recent developments in the mechanism of anticancer agents based on electron transfer, reactive oxygen species and oxidative stress","volume":"11","author":"Kovacic","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"issue":"32","key":"10.1016\/j.ebiom.2020.102715_bib0040","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.1806296115","article-title":"Elesclomol restores mitochondrial function in genetic models of copper deficiency","volume":"115","author":"Soma","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102715_bib0041","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/iub.2002","article-title":"The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug","volume":"71","author":"Ngwane","year":"2019","journal-title":"IUBMB Life"},{"issue":"420","key":"10.1016\/j.ebiom.2020.102715_bib0042","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis","volume":"9","author":"Lagares","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2020.102715_bib0043","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3389\/fphys.2019.01101","article-title":"Direct and indirect roles of macrophages in hypertrophic scar formation","volume":"10","author":"Feng","year":"2019","journal-title":"Front Physiol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102715_bib0044","doi-asserted-by":"crossref","first-page":"21662","DOI":"10.1002\/jcp.28830","article-title":"Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids","volume":"234","author":"Yuan","year":"2019","journal-title":"J Cell Physiol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:32:14Z","timestamp":1778873534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420300906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"alternative-id":["S2352396420300906"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102715","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102715"}}